Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Five Below Inc (FIVE) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance

Five Below IncTrade
Royalty Pharma plc Class A Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

Five Below Inc vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Five Below Inc trades at $209.72 (market cap $11.25B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.2 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 2.2× Five Below Inc's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Five Below Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Five Below Inc for 46 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.

FIVERPRX
Market Cap
$11.25B$25.27B
Volume
986,5463,671,183
Sector
Consumer CyclicalHealth
52-Week High
$262.72$63.96
52-Week Low
$138.49$35.44
Typical Hold Time
46 Days0 Days
Enterprise Value
$12.10B$32.50B
Dividend Yield
—1.66%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Five Below Inc

Five Below (FIVE) trades at $209.56, down 0.17% on the day, with a bearish technical signal despite bullish oscillators. The company shows strong profitability with 40.26% gross margins and 28.25% ROE, though net margins declined to 6.54% in 2025. Recent earnings beats and a raised 2026 outlook highlight growth momentum, supported by store expansion and digital initiatives. Cash flow improved significantly in 2025 with $152M net inflow after two years of negative flows.

The stock offers substantial upside to the $298.44 consensus target, with 60% analyst buy ratings and no sell recommendations. Key risks include premium valuation (P/E 18.32) and execution pressure amid consumer spending concerns. Growth catalysts include the $600M buyback and store revamp strategy, though technical resistance near $212 may limit near-term gains.

Royalty Pharma plc Class A Ordinary Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FIVE
83% Buy17% Sell
Avg holding period · 46 Days
RPRX
100% Buy0% Sell
Avg holding period · 0 Days

About Five Below Inc

Five Below is a value-oriented retailer that operated 1,190 stores in the United States as of the end of fiscal 2021. Catering to teen and preteen consumers, stores feature a wide variety of merchandise, the vast majority of which is priced below $6. The assortment focuses on discretionary items in several categories, particularly leisure (such as sporting goods, toys, and electronics

Read more on FIVE →

About Royalty Pharma plc Class A Ordinary Shares

Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.

Read more on RPRX →